Building successful life sciences companies.

With over $200 million of committed capital under management, Genesys is one of the largest Canadian-based exclusively focused on the life sciences industry. View our portfolio.

Building companies, accelerating development.

Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising life science investment opportunities.

Investor Login

Sign in to our secure investor area to receive personalized updates and information. Login now »

Recent Additions

Invitae Offers Multi-Gene Testing for Hereditary Pancreatic Cancer, Providing Clinicians with a Reliable, Fast, Affordab
SAN FRANCISCO, June 12, 2014 - Invitae Corporation, a genetic information company, today announced that it now offers multi-gene testing... Read more
Naurex Reports Positive Top-Line 2b Results for Novel Antidepressant GLYX-13 and Advances NRX-1074 into Phase 2 Depressi
EVANSTON, IL, MAY 6, 2014 - Naurex Inc., a privately held biopharmaceutical company leveraging its unique platform to develop novel... Read more